AI Drug Discovery Pioneer Converge Bio Secures Staggering $25M to Revolutionize Pharmaceutical R&D
In a significant move that underscores the accelerating fusion of artificial intelligence and life sciences, Boston- and Tel Aviv-based startup Converge Bio announced.

